We hypothesize that GR SNPs resulting in increased transactivation are associated with a lower age of diabetes onset and impaired glycemic control, and SNPs resulting in diminished transrepression are associated with a higher level of inflammation in patients with established type 2 diabetes. Here, NR3C1 is linked to type 2 diabetes mellitus.